Comment from National Leiomyosarcoma Foundation

Summary: The National Leiomyosarcoma Foundation supports the Haystack Project Petition for Rulemaking, advocating for a modernized regulatory framework for rare disease clinical trials. They argue for disease-specific clinical endpoints, greater flexibility in study designs (such as adaptive trials and real-world evidence), and the integration of natural history data to better reflect the realities of rare disease research.